Cargando…

MAFLD and NAFLD in the prediction of incident chronic kidney disease

Whether metabolic dysfunction-associated fatty liver disease (MAFLD) can replace nonalcoholic fatty liver disease (NAFLD) is under debate. This study evaluated which definition better predicted incident chronic kidney disease (CKD). This was a 5.3-year (range, 2.8–8.3) retrospective cohort study of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwon, So Yoon, Park, Jiyun, Park, So Hee, Lee, You-Bin, Kim, Gyuri, Hur, Kyu Yeon, Koh, Janghyun, Jee, Jae Hwan, Kim, Jae Hyeon, Kang, Mira, Jin, Sang-Man
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889784/ https://www.ncbi.nlm.nih.gov/pubmed/36720976 http://dx.doi.org/10.1038/s41598-023-27762-6

Ejemplares similares

Increased risk of incident diabetes in patients with MAFLD not meeting the criteria for NAFLD
por: Park, So Hee, et al.
Publicado: (2023)

Low Household Income Status and Death from Pneumonia in People with Type 2 Diabetes Mellitus: A Nationwide Study
por: Lee, You-Bin, et al.
Publicado: (2023)

The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study
por: Park, Jiyun, et al.
Publicado: (2022)

Insulin Fact Sheet in Type 1 and 2 Diabetes Mellitus and Trends of Antidiabetic Medication Use in Insulin Users with Type 2 Diabetes Mellitus: 2002 to 2019
por: Park, Jiyun, et al.
Publicado: (2023)

The association of hepatic steatosis and fibrosis with heart failure and mortality
por: Park, Jiyun, et al.
Publicado: (2021)

NAFLD/MAFLD: New Evidence
por: Mantovani, Alessandro, et al.
Publicado: (2023)

Editorial: The NAFLD-MAFLD conundrum
por: Dalbeni, Andrea, et al.
Publicado: (2023)

Impact of continuous glucose monitoring on glycemic control and its derived metrics in type 1 diabetes: a longitudinal study
por: Cho, So Hyun, et al.
Publicado: (2023)

Association between cholesterol levels and dementia risk according to the presence of diabetes and statin use: a nationwide cohort study
por: Lee, You-Bin, et al.
Publicado: (2022)

MAFLD: How is it different from NAFLD?
por: Gofton, Cameron, et al.
Publicado: (2023)

Comparison of MAFLD and NAFLD Characteristics in Children
por: Xing, Yunfei, et al.
Publicado: (2023)

Mean and visit‐to‐visit variability of glycated hemoglobin, and the risk of non‐alcoholic fatty liver disease
por: Yoo, Jee Hee, et al.
Publicado: (2020)

Mean and Variability of Lipid Measurements and Risk for Development of Subclinical Left Ventricular Diastolic Dysfunction
por: Park, Jiyun, et al.
Publicado: (2022)

Risk of early mortality and cardiovascular disease according to the presence of recently diagnosed diabetes and requirement for insulin treatment: A nationwide study
por: Lee, You‐Bin, et al.
Publicado: (2021)

Association between lipid variability and the risk of mortality in cancer patients not receiving lipid-lowering agents
por: Kim, Seohyun, et al.
Publicado: (2023)

COVID-19 and MAFLD/NAFLD: An updated review
por: Nowroozi, Ali, et al.
Publicado: (2023)

Effects of low skeletal muscle mass and sarcopenic obesity on albuminuria: a 7-year longitudinal study
por: Yoo, Jee Hee, et al.
Publicado: (2020)

The NAFLD–MAFLD debate through the lens of the Arab world
por: Tharwat, Mina, et al.
Publicado: (2022)

NAFLD vs MAFLD: South Asian NAFLD Patients don't Favor Name Change
por: Singh, Shivaram P, et al.
Publicado: (2022)

Aldosterone Immunoassay-Specific Cutoff Value for Seated Saline Suppression Test for Diagnosing Primary Aldosteronism
por: Kwon, So Yoon, et al.
Publicado: (2022)

The associations between changes in hepatic steatosis and heart failure and mortality: a nationwide cohort study
por: Park, Jiyun, et al.
Publicado: (2022)

NAFLD and MAFLD as emerging causes of HCC: A populational study
por: Myers, Shuna, et al.
Publicado: (2021)

MAFLD Not NAFLD is Associated with Impairment of Health-related Quality of Life
por: Attia, Dina, et al.
Publicado: (2022)

Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition?
por: Lonardo, Amedeo
Publicado: (2021)

Cardiovascular and renal burdens among patients with MAFLD and NAFLD in China
por: Wang, Yuying, et al.
Publicado: (2022)

From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications
por: Boccatonda, Andrea, et al.
Publicado: (2023)

Utility of Serum Albumin for Predicting Incident Metabolic Syndrome According to Hyperuricemia
por: Lee, You-Bin, et al.
Publicado: (2018)

Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma
por: Ahn, Jiyeon, et al.
Publicado: (2021)

Increase in relative skeletal muscle mass over time and its inverse association with metabolic syndrome development: a 7-year retrospective cohort study
por: Kim, Gyuri, et al.
Publicado: (2018)

East Asian diet‐mimicking diet plan based on the Mediterranean diet and the Dietary Approaches to Stop Hypertension diet in adults with type 2 diabetes: A randomized controlled trial
por: Jin, Sang‐Man, et al.
Publicado: (2020)

Validation of nonalcoholic fatty liver disease (NAFLD) related steatosis indices in metabolic associated fatty liver disease (MAFLD) and comparison of the diagnostic accuracy between NAFLD and MAFLD
por: Chen, Jie, et al.
Publicado: (2023)

Regular Exercise Is Associated with a Reduction in the Risk of NAFLD and Decreased Liver Enzymes in Individuals with NAFLD Independent of Obesity in Korean Adults
por: Bae, Ji Cheol, et al.
Publicado: (2012)

A 4-Week, Two-Center, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of EOPatch in Well-Controlled Type 1 Diabetes Mellitus
por: Park, Jiyun, et al.
Publicado: (2022)

From NAFLD to MAFLD: a “redefining” moment for fatty liver disease
por: Zheng, Kenneth I., et al.
Publicado: (2020)

Open Issues in the Transition from NAFLD to MAFLD: The Experience of the Plinio Study
por: Baratta, Francesco, et al.
Publicado: (2021)

From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights
por: Gatzios, Alexandra, et al.
Publicado: (2022)

Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease
por: Musio, Alessandra, et al.
Publicado: (2023)

Association of Urinary N-Acetyl-β-D-Glucosaminidase with Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Mellitus without Nephropathy
por: Choi, Min Sun, et al.
Publicado: (2021)

Serum Calcium and the Risk of Incident Metabolic Syndrome: A 4.3-Year Retrospective Longitudinal Study
por: Baek, Jong Ha, et al.
Publicado: (2017)

Association of Serum Vitamin C With NAFLD and MAFLD Among Adults in the United States
por: Xie, Zhi-Qin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p0cjkj2n618pe3uob6i4bh80pn